Chy-3 mice are Vegfc haploinsufficient and exhibit defective dermal superficial to deep lymphatic transition and dermal lymphatic hypoplasia

Developmental Dynamics

Volumn 236, Issue 8, 2007, Pages 2346-2355

  Dellinger, Michael T ^a   Hunter, Robert J ^b   Bernas, Michael J ^b   Witte, Marlys H ^b   Erickson, Robert P ^a,b  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Chy mice; Chy 3 mice; Chylous ascites; Lymph vasculogenesis; Lymphangiogenesis; Lymphatic development; Lymphatic imaging; Lymphatic phenotyping; Lymphedema; Milroy disease; Vegf c; Vegfr 3

Indexed keywords

VASCULOTROPIN C;

ARTICLE; AXILLARY LYMPH NODE; CHROMOSOME DELETION; CHYLOUS ASCITES; CONTROLLED STUDY; GENETIC MARKER; GENOTYPE; HETEROZYGOSITY; HYPOPLASIA; INGUINAL LYMPH NODE; LYMPHANGIOGENESIS; LYMPHANGIOGRAPHY; LYMPHATIC SYSTEM DISEASE; LYMPHEDEMA; MILROY DISEASE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ASCITES; CHROMOSOME DELETION; GENOTYPE; LOWER EXTREMITY; LYMPH NODES; LYMPHATIC SYSTEM; LYMPHATIC VESSELS; LYMPHEDEMA; MALE; MICE; MICE, MUTANT STRAINS; PHENOTYPE; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

ANIMALIA; MUS;

EID: 34548070757     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.21208     Document Type: Article

References (39)

1. Buttler K, Kreysing A, von Kaisenberg CS, Schweigerer L, Gale N, Papoutsi M, Wilting J. 2006. Mesenchymal cells with leukocyte and lymphendothelial characteristics in murine embryos. Dev Dyn 235:1554-1562.
2. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L, Alitalo K. 1998. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 95:14389-14394.
3. Cattanach BM, Burtenshaw MD, Rasberry C, Evans EP. 1993. Large deletions and other gross forms of chromosome imbalance compatible with viability and fertility in the mouse. Nat Genet 3:56-61.
4. Dumont DJ, Jussila L, Taipale J, Lymboussaki A, Mustonen T, Pasusola K, Breitman M, Alitalo K. 1998. Cardiovascular failure in mouse embryos deficient in VEGF receptor-3. Science 282:946-949.
5. Ferrell RE, Levinson KL, Esman JH, Kimak MA, Lawrence EC, Barmada MM, Finegold DN. 1998. Hereditary lymphedema: evidence for linkage and genetic heterogeneity. Hum Mol Genet 7:2073-2078.
6. Földi M, Földi E, Kubik S, editors. 2003. Textbook of lymphology. 5th ed. Muchen: Urban and Fischer, p. 689.
7. Gale NW, Thurston G, Hackett SF, Renard R, Wang Q, McClain J, Martin C, Witte C, Witte MH, Jackson D, Suri C, Campochiaro PA, Wiegand SJ, Yancopoulos GD. 2002. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1. Dev Cell 3:411-423.
8. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. 2000. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 67:295-301.
9. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K. 1997. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276:1423-1425.
10. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, Saksela O, Kalkkinen N, Alitalo K. 1996. A novel vascular endothelial growth factor, VEGFC, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15:290-298.
11. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K. 1998. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 16:3898-3911.
12. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VWM, Fang GH, Dumont D, Breitman M, Alitalo K. 1995. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92:3566-3570.
13. Kampmeier OF. 1912. The development of the thoracic duct in the pig. Am J Anat 13:401-475.
14. Kampmeier OF. 1969. Evolution and comparative morphology of the lymphatic system. Springfield: Charles C. Thomas.
15. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, Alitalo K, Finegold DN. 2000. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 25:153-159.
16. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, Bueler H, Eichmann A, Kauppinen R, Kettunen MI, Yla-Herttuala S, Finegold DN, Ferrell RE, Alitalo K. 2001. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci U S A 98:12677-12682.
17. Karkkainen MJ, Haiko P, Sainio K, Partanen J, Taipale J, Petrova TV, Jeltsch M, Jackson DG, Talikka M, Rauvala H, Betsholtz C, Alitalo K. 2004. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Nat Immunol 5:74-80.
18. Kriederman BM, Myloyde TL, Witte MH, Dagenais SL, Witte CL, Rennels M, Bernas MJ, Lynch MT, Erickson RP, Caulder MS, Miura N, Jackson D, Brooks BP, Glover TW. 2003. FOXC2 haploinsufficient mice are a model for human autosomal dominant lymphedema-distichiasis syndrome. Hum Mol Genet 12:1179-1185.
19. Kuchler AM, Gjini E, Peterson-Maduro J, Cancilla B, Wolburg H, Schulte-Merker S. 2006. Development of the zebrafish lymphatic system requires VEGFC signaling. Curr Biol 16:1244-1248.
20. Laborda E, Santesteban P, Samaniego E. 2005. Unusual lymphatic drainage pattern in a patient with lymphedema of lower extremities. Lymphology 38:16-17.
21. Liu DP, Schmidt C, Billings T, Davisson MT. 2003. Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome. Biotechniques 35:1170-1180.
22. Makinen T, Adams RH, Bailey J, Lu Q, Ziemiecki A, Alitalo K, Klein R, Wilkinson GA. 2005. PDZ interaction site in ephrinb2 is required for the remodeling of lymphatic vasculature. Genes Dev 19:397-410.
23. Ny A, Koch M, Schneider M, Neven E, Tong RT, Maity S, Fischer C, Plaisance S, Lambrechts D, Heligon C, Terclavers S, Ciesiolka M, Kalin R, Man WY, Senn I, Wyns S, Lupu F, Brandli A, Vleminckx K, Collen D, Dewerchin M, Conway EM, Moons L, Jain RK, Carmeliet P. 2005. A genetic Xenopus laevis tadpole model to study lymphangiogeneis. Nat Med 11:998-1004.
24. Oh SJ, Jeltsch MM, Birkenhager R, McCarthy JEG, Weich HA, Christ B, Alitalo K, Wilting J. 1997. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188:96-109.
25. Petrova TV, Karpanen T, Norrmen C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Yla-Herttuala S, Miura N, Alitalo K. 2004. Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis. Nat Med 10:974-981.
26. Richards G, Bernas M, Hunter R, Kaylor B, Gmitro A, Witte MH. 2007. Rhodamine-based optical imaging of the murine lymphatic system. Lymphology 40(Suppl): In press.
27. Saaristo A, Veikkola T, Enholm B, Hytonen M, Arola J, Pajusola K, Turnen P, Jelstch M, Karkkainen MJ, Kerjaschki D, Bueler H, Yla-Herttuala S, Alitalo K. 2002. Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 16:1041-1049.
28. Sabin FR. 1902. On the origin and development of the lymphatic system from the veins and the development of the lymph hearts and the thoracic duct in the pig. Am J Anat 1:367-389.
29. Sabin FR. 1904. On the development of the superficial lymphatics in the skin of the pig. Am J Anat 3:183-195.
30. Sabin FR. 1909. The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. Am J Anat 9:43-91.
31. Schneider M, Othoman-Hassan K, Christ B, Wilting J. 1999. Lymphangiogenesis in the avian wing bud. Dev Dyn 216:311-319.
32. Wigle JT, Oliver G. 1999. Prox1 function is required for the development of the murine lymphatic system. Cell 98:769-778.
33. Wigle JT, Harvey N, Detmar M, Lagutina I, Grovseld G, Gunn MD, Jackson DG, Oliver G. 2002. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO 21:1505-1513.
34. Wilting J, Schneider M, Papoutsi M, Alitalo K, Christ B. 2000. An avian model for studies of embryonic lymphangiogenesis. Lymphology 33:81-94.
35. Wilting J, Aref Y, Huang R, Tomarev SI, Schwigerer L, Christ B, Valasek P, Papoutsi M. 2006. Dual origin of avian lymphatics. Dev Biol 292:165-173.
36. Witte MH, Way DL, Witte CL, Bernas M. 1997. Lymphangiogenesis: mechanisms, significance and clinical implications. In: Goldberg ID, Rosen EM, editors. Regulation of angiogenesis. Basel: Birkhaueser Verlag. p 65-112.
37. Witte MH, Erickson R, Bernas M, Andrade M, Reiser F, Conlon W, Hoyme HE, Witte C. 1998. Phenotypic and genotypic heterogeneity in familial Milroy lymphedema. Lymphology 31:145-155.
38. Witte MH, Bernas MJ, Martin CP, Witte CL. 2001. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech 55:122-145.
39. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM. 2006. Live imaging of lymphatic development in the zebrafish. Nat Med 12:711-716.